PLASMA ?-GLUCURONIDASE LEVELS IN BREAST CANCER
1960

Plasma Beta-Glucuronidase Levels in Breast Cancer

Sample size: 47 publication Evidence: high

Author Information

Author(s): B. L. Whitaker

Primary Institution: Royal Free Hospital

Hypothesis

The study investigates the plasma levels of beta-glucuronidase in patients with breast cancer compared to normal controls.

Conclusion

The study found that plasma beta-glucuronidase levels are significantly higher in breast cancer patients compared to normal women.

Supporting Evidence

  • The mean beta-glucuronidase level for breast cancer patients was 6.90 units, significantly higher than the control group's mean of 3.58 units.
  • 51% of breast cancer cases had enzyme levels within the normal range, while 49% had elevated levels.
  • Stage I and II breast cancer cases had significantly raised enzyme levels compared to controls.

Takeaway

This study looked at a special enzyme in the blood of women with breast cancer and found that they had more of it than women without cancer.

Methodology

Blood samples were taken, plasma was separated and stored, and enzyme levels were measured using a modified method of estimation.

Limitations

The study does not provide data on the effects of treatment on enzyme levels, which will be reported later.

Participant Demographics

The study included 50 normal women aged 18 to 70 and 47 patients with breast carcinoma.

Statistical Information

P-Value

<0.0000001

Statistical Significance

p<0.0000001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication